Biote (BTMD) Stock: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$1.15
-0.01 (-0.86%)
▼
5d:
-5.74%
30d:
-31.95%
90d:
-49.56%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BTMD shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BTMD shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.80
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$1.74
34.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.15, which is considered oversold relative to its 30-day fair value range of $1.24 to $1.56. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.6) compared to its historical average (3.2). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BTMD is in a strong downtrend. The price is currently testing key support at $1.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.61 (+127.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BTMD is in a strong downtrend. The price is currently testing key support at $1.15. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $2.61 (+127.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.24 -
$1.56
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 127.1% below Wall St target ($2.61)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.24 -
$1.56
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.15
Resistance Level
$1.40
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.56
Wall Street Target
$2.61
(+127.1%)
Revenue Growth (YoY)
-9.5%
Earnings Growth (YoY)
-83.8%
Profit Margin
3.2%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
2.6 vs 3.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$1.06
(-8%)
2-Year Target
$0.98
(-15%)
3-Year Target
$0.91
(-21%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
$1.14
(-1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 28.6%)
$19.51
(+1597%)
Base:
(SPY PE: 2.6, Growth: 28.6%)
$2.44
(+113%)
Bear:
(PE: 2.2, Growth: 28.6%)
$2.08
(+81%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (8x PE), but valuation improves significantly next year (3x PE) as earnings recover.
Trailing PE: 8.29 | Current EPS (TTM): $0.14
Bull Case
$2.55
(+122%)
Analyst growth 100.0%, PE expands to 9.1
Base Case
$2.32
(+102%)
Market implied 100.0%, PE stable at 8.3
Bear Case
$0.79
(-31%)
Severe decline -20.0%, PE contracts to 7.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.6 to 3.2
Stabilization Target:
$1.44
(+25.2%)
PE Expansion Potential:
+25.2%
Share & Embed Analysis
Last updated: October 03, 2026 8:53 AM ET
Data refreshes hourly during market hours. Next update: 9:53 AM
Data refreshes hourly during market hours. Next update: 9:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$454 | 48 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$134 | 67 BUY |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
